Many of these combination panels have demonstrated an excellent ability to discriminate between active LN and absence of LN, with one panel including AGP-1, ceruloplasmin, L-PGDS and transferrin demonstrating a perfect ability (AUC 1) to predict LN activity, reaching 100% sensitivity and specificity(44). The gene discussed is PTGDS; the disease is lobular neoplasia.